We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Plants Provide Diagnostic Reagent for West Nile Virus

By LabMedica International staff writers
Posted on 15 Nov 2012
A method has been developed for testing for West Nile Virus (WNV), using plants to produce biological reagents for detection and diagnosis. More...


A plant expression system has been investigated for protein production due to its low-cost and high-scalability nature and its ability to make appropriate posttranslational modifications.
Scientists at Arizona State University (Tempe, AZ, USA) explored the feasibility of using plant transient expression systems to produce two groups of protein reagents that are required for the detection and diagnosis of WNV infection. One was a recombinant antigen derived from the domain III (DIII) of WNV envelope (E) protein and the second, a monoclonal antibody (mAb E16) that specifically recognizes WNV DIII.

High expression levels of both reagents were observed in two kinds of plants: Nicotiana benthamiana, which is a close relative of tobacco, and lettuce. The two reagents may be readily purified to greater than 95% and retain their native functionality and specificity. The binding specificity of plant-derived E16 at various concentrations of this mAb were incubated with either DIII of WNV or DIII of Dengue virus serotype 2 (DENV-2) that was immobilized on an enzyme linked immunosorbent assay (ELISA) plate. A mammalian cell-culture-derived E16 and a generic human immunoglobulin G (IgG) (Southern Biotech, Birmingham, AL, USA) were used as the positive and negative control, respectively.

The binding to WNV DIII increased with the concentration of lettuce or N. benthamiana-derived E16 in the reaction in a similar manner as the mammalian cell-derived E16 positive control. In contrast, none of the E16s showed specific binding to DIII of DENV-2. The negative control, a generic human IgG, showed no specific binding to either WNV or DENV-2 DIII. These results indicate that the specific avidity for WNV DIII is retained by the plant-derived E16s. This high specificity makes it a valuable reagent in obtaining unambiguous diagnostic results for detecting WNV and WNV infection.

Qiang Chen, PhD, the senior author said, “Our test will improve the accuracy of diagnosis, leading to the proper treatment of patients affected by WNV. The plant-derived monoclonal antibody we examined is not only low-cost, but highly specific for WNV antigen and does not recognize antigens from other flaviviruses.” The study was published in the October 2012 issue of the Journal of Biomedicine and Biotechnology.

Related Links:
Arizona State University
Southern Biotech


Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Anti-Thyroid Peroxidase Assay
LIAISON Anti-TPO
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
Image: Pancreatic cancer diagnosis (Photo courtesy of World Journal of Gastroenterology)

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.